GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Cross Corp (XKRX:006280) » Definitions » Sale Of Investment

Green Cross (XKRX:006280) Sale Of Investment : ₩58,009 Mil (TTM As of Mar. 2025)


View and export this data going back to 1989. Start your Free Trial

What is Green Cross Sale Of Investment?

Green Cross's sale of investment for the three months ended in Mar. 2025 was ₩29,265 Mil. It means Green Cross gained ₩29,265 Mil from selling investments. Green Cross's sale of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ₩58,009 Mil.

Compared with last quarter (₩13,000 Mil in Dec. 2024 ), Green Cross gained more money from selling investments in Mar. 2025 (₩29,265 Mil).


Green Cross Sale Of Investment Historical Data

The historical data trend for Green Cross's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Cross Sale Of Investment Chart

Green Cross Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 153,463.12 50,162.88 49,932.39 41,335.19 33,889.14

Green Cross Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,144.86 3,800.00 11,944.29 13,000.00 29,264.76

Green Cross Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩58,009 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Cross Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Green Cross's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Cross Business Description

Traded in Other Exchanges
N/A
Address
303 Bojeong-Dong, Giheung-Gu, Yongin, Gyeonggi, KOR, 449-070
Green Cross Corp is one of the global leaders in the healthcare sector. The Montreal-based biopharmaceutical company primarily develops intravenous immunoglobulin (IVIG), a key therapeutic solution for the treatment of patients with infectious and immune diseases, and albumin, used as a blood-volumizing agent and in the treatment of burns. Currently, the company has a global presence through its association with various subsidiaries.

Green Cross Headlines

No Headlines